By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Next-generation sequencing technology firm GnuBio has completed its Series A equity financing round raising $8 million, which the company will use to accelerate the beta program for its platform.

The round had 12 participants, though company CEO John Boyce declined to identify them. GnuBio raised the first $3 million of the round in November and raised the remaining $5 million upon hitting certain milestones, he said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genomic study of group B Streptococcus evolution, selection on the X chromosome in great apes, and more.

Changing the fat and fiber content of people's diets affects their gut microbiome, metabolome, and colon cancer risk, researchers say.

Broken links are found throughout academic publications, and some services are trying to combat such link decay.

Nick Stockton at Wired says that a pause in studying genome-editing tools should be used to find a path forward.